Crohn Disease Clinical Trials in Tyler, Texas

4 studies are recruiting for crohn disease in Tyler, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in …

    Stage
    Phase 3
    Ages
    Any age
    Site
    Tyler Research Institute ( Site 0294), Tyler, Texas
    Locations
    37 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06651281 on ClinicalTrials.gov

  2. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Tyler Research Institute, LLC, Tyler, Texas
    Locations
    370 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196722 on ClinicalTrials.gov

  3. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    The University of Texas Health Science Center at Tyler, Tyler, Texas
    Locations
    160 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07499232 on ClinicalTrials.gov

  4. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive [worsens with time] and life-threatening disease of the intesti…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Tyler Research Institute, LLC, Tyler, Texas
    Locations
    142 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07577843 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.